ITI Pharma and Healthcare Fund: AUM ₹19 Cr, expense ratio 0.92%, 1Y return +9.43%. Track returns, risk and NAV history.
| Fund House (AMC) | ITI Mutual Fund |
|---|---|
| Category | Equity Scheme - Sectoral/ Thematic |
| Scheme Code | 149268 |
| ISIN | INF00XX01BO9 |
| AUM | ₹19 Cr |
| Expense Ratio | 0.92% |
| Launch Date | 18-10-2021 (5.1 yrs) |
| 1-Year Return | +9.43% |
| 3-Year Return | +20.30% |
| 5-Year Return | +14.34% |
| Alpha (vs Nifty 50) | +12.93% |
| Standard Deviation | 13.70% |
| Sortino Ratio | 0.31 |
| Exit Load | Entry Load – Not Applicable Exit Load - • 1% if redeemed or switched out on or before completion of 12 months from the date of allotment of units; • Nil, if redeemed or switched out after completion of 12 months from the date of allotment of units. |
You can check the live AMFI NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option (Scheme Code: 149268) on this page or in our Live Data scanner.
The expense ratio of ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 0.92% per annum, deducted daily from the scheme's Net Asset Value (NAV).
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option manages Assets Under Management (AUM) of approximately ₹19 Cr and was launched on 18-10-2021.
Trailing annualized returns for ITI Pharma and Healthcare Fund - Direct Plan - Growth Option are 1-Year: +9.43%, 3-Year: +20.30%, 5-Year: +14.34%. Past performance is not indicative of future results.
The AMFI scheme code for ITI Pharma and Healthcare Fund - Direct Plan - Growth Option is 149268 and its ISIN is INF00XX01BO9. It is managed by ITI Mutual Fund.